Will WHO’s new guidance spur hepatitis B immunisation?
Despite vaccine developments signalling advancements in the diagnosis, prevention and treatment of hepatitis B, the World Health Organization’s (WHO) 2024…
All articles by Natasha Spencer-Jolliffe
Natasha Spencer-Jolliffe
@NatashaSpenJoll
Natasha Spencer-Jolliffe is a freelance journalist, and has written about mental health, fertility, and new pharmaceutical discoveries. In her reporting, she explores people in the healthcare industry and the wider world from scientific, sociological, legal, technological, environmental and leadership perspectives.
-
-
Can supermarket pharmacies plug urgent healthcare gaps?
In April, retail giant Asda launched its online prescription service, marking a major milestone and “first” for a supermarket in…
-
Lula’s progress plan for Brazil: A year on
On 30 May 2023, President Lula da Silva assembled the first South American summit in nearly a decade. In reviving…
-
Harnessing pharmacovigilance to turn reactive investigation into active discovery
Pharmacovigilance uses science and action to detect, assess, understand and prevent adverse events (AEs) or other issues relating to medicines…
-
Continuous monitoring expands aseptic knowledge and data in real time
Highlighted by the introduction of regulatory stipulation in August 2023, real-time monitoring for cleanrooms involves using particle counters and other…
-
Can pharma overcome generative AI’s bias problem?
Generative artificial intelligence (AI) or gen AI refers to algorithms that can produce new content such as codes, text, images…
-
Is HIV-TB coinfection treatment entering a new frontier?
Tuberculosis or TB is the leading cause of death in people with HIV. Moreover, people living with HIV are at…
-
Traceability technologies tighten supply chain fakery
Counterfeit drug production and distribution has increased in recent years. Disruption from the Covid-19 pandemic, business resilience impacts, and rapid…
-
Patient organisations need to tackle transparency
As patient organisations play a part in regulatory issues and contribute to health institutions’ guideline development, recent research finds many…
-
A ‘sense of urgency’ swirls in the UK pharma regulatory landscape
More than seven years since Brexit and almost four years since the arrival of Covid-19, the last year saw the…